05 June, 2017
Following the completion of the transaction, the insider now directly owns 27,062 shares of the company's stock, valued at $758,006.62. The medical device company reported ($0.02) EPS for the quarter, topping the Zacks' consensus estimate of ($0.03) by $0.01. Sectoral Asset Management Inc who had been investing in Nxstage Medical for a number of months, seems to be less bullish one the $1.36 billion market cap company. The stock decreased 0.37% or $0.36 during the last trading session, reaching $97.61. NVIDIA Corporation (NASDAQ:NVDA) has risen 212.28% since June 1, 2016 and is uptrending. It has underperformed by 6.19% the S&P500.
James E. Flynn increased its stake in Nxstage Medical Inc (NXTM) by 3.88% based on its latest 2016Q4 regulatory filing with the SEC. The third largest holder is Gilder Gagnon Howe & Co Llc, which now holds $112.15 million worth of this stock and that ownership represents almost 7.9% of its market capitalization. The hedge fund run by Jerome Pfund held 891,313 shares of the health care company at the end of 2016Q4, valued at $23.36M, down from 1.20 million at the end of the previous reported quarter. Rathbone Brothers Pcl has 0.01% invested in NxStage Medical, Inc. It is 0.00% or $0 reaching $21.66 per share. (NASDAQ:NXTM) is a huge mover today! It has outperformed by 4.48% the S&P500.
Investors sentiment decreased to 0.85 in 2016 Q4. It is negative, as 15 investors sold NXTM shares while 67 reduced holdings. (NASDAQ:NXTM). 1.33M are owned by Jennison Ltd Liability Corp. Pinebridge Investments Ltd Partnership reported 29,475 shares. Tower Research Ltd Limited Liability Company (Trc) has 0.01% invested in SINA Corp (NASDAQ:SINA). Chicago Equity Prtn Limited Liability Corp holds 0.06% of its portfolio in NxStage Medical, Inc. NxStage Medical, Inc. has a 12-month low of $18.28 and a 12-month high of $30.80.
Nxstage Medical Incorporated (NASDAQ:NXTM) had an increase of 1.99% in short interest. Qs Invsts Limited Liability, New York-based fund reported 103,912 shares. The Veritable Lp holds 19,348 shares with $2.07 million value, up from 15,540 last quarter. Geode Cap Mgmt Limited Liability Co stated it has 0.01% in NxStage Medical, Inc. Fmr Llc owns $169.32 million in Nxstage Medical, Inc., which represents roughly 11.92% of the company's market cap and approximately 11.55% of the institutional ownership. Deerfield Management Company acquired 159,021 shares as Nxstage Medical Inc (NXTM)'s stock declined 27.12%. (NASDAQ:NXTM) for 257,500 shares. Ww Asset stated it has 4,349 shares or 0.01% of all its holdings. Opportunities Mngmt Ltd Co has 96,525 shares for 0.52% of their portfolio. Perceptive Advsrs Ltd Co stated it has 1.93M shares. It also increased its holding in Intersect Ent Inc (NASDAQ:XENT) by 366,797 shares in the quarter, for a total of 534,937 shares, and has risen its stake in Biomarin Pharmaceutical Inc (NASDAQ:BMRN).
Since December 13, 2016, it had 0 buys, and 40 sales for $9.12 million activity. Shares for $90,685 were sold by Swan Winifred L. $118,938 worth of NxStage Medical, Inc. (NASDAQ:NXTM) for 5,689 shares. Sectoral Asset Management Inc sold 308,556 shares as the company's stock declined 27.12% while stock markets rallied. Slumped Today" with publication date: "May 03, 2017. (NASDAQ:NXTM) was released by: Fool.com and their article: "Why Nxstage Medical, Inc". (NASDAQ:NXTM) on Tuesday, August 2 with "Buy" rating. Therefore 83% are positive. Comerica Comml Bank has 4,008 shares. $23.10's average target is 6.65% above currents $21.66 stock price. Jefferies Group LLC reaffirmed a "buy" rating and set a $38.00 price objective on shares of NxStage Medical in a research report on Wednesday, March 22nd. As per Thursday, March 31, the company rating was reinitiated by Piper Jaffray. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Canaccord Genuity restated a "buy" rating and issued a $32.00 price target on shares of NxStage Medical in a report on Monday, May 8th. (NASDAQ:NXTM) earned "Outperform" rating by Northland Capital on Tuesday, June 28. Sterne Agee CRT initiated the stock with "Buy" rating in Friday, December 11 report. 420,352 shares of the stock traded hands. BELINGARD JEAN-LUC had sold 992 shares worth $141,052 on Tuesday, May 9. ANDERSON KERRII B sold 1,992 shares worth $278,880. Its up 0.07, from 0.86 in 2016Q3. 14 funds opened positions while 17 raised stakes. National Bank Of Montreal Can holds 94,288 shares. Everpoint Asset Management Ltd Llc holds 0.05% or 100,000 shares. Fdx Advsr has 25,209 shares for 0.09% of their portfolio. 51,988 are owned by British Columbia Invest Mgmt Corporation. Toronto Dominion Bancorporation holds 0.01% or 168,400 shares. Tradewinds Capital Mngmt reported 560 shares. Bridger Management Limited Com has 1.75% invested in Laboratory Corp. of America Holdings (NYSE:LH). Proshare Lc holds 0.01% or 10,262 shares. (NASDAQ:NXTM) earned "Buy" rating by BTIG Research on Friday, December 18. Therefore 50% are positive. The highest EPS estimate is $0.00 and the lowest is ($0.02). The stock was sold at an average price of $21.36, for a total value of $91,848.00. Nvidia Corporation had 102 analyst reports since August 3, 2015 according to SRatingsIntel.
Institutional investors now hold around $1.47 billion or 96.4% in NXTM stock. M Partners maintained it with "Neutral" rating and $28 target in Wednesday, November 4 report. The rating was maintained by Brean Capital with "Buy" on Wednesday, September 14. The stock has "Buy" rating by Credit Suisse on Thursday, May 25.
